Minot Wealth Management »

Avalo Therapeutics shares owned by Minot Wealth Management

Quarter-by-quarter ownership of Avalo Therapeutics shares owned by Minot Wealth Management from 13F filings

Historical chart of Minot Wealth Management investment in Avalo Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Avalo Therapeutics held by Minot Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Avalo Therapeutics by Minot Wealth Management

Quarter filed Position value Share count Share price at filing
2022-06-30 $17k 35k 0.49
2022-03-31 $25k 35k 0.72
2021-12-31 $59k 35k 1.70
2021-09-30 $225k 103k 2.18

More positions owned by Minot Wealth Management

Schwab Strategic Tr Us Dividend Eq (SCHD)
Apple (AAPL)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Microsoft Corporation (MSFT)
Abbvie (ABBV)
Spdr Ser Tr S&p 400 Mdcp Val (MDYV)
UnitedHealth (UNH)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Accenture Plc Ireland Shs Class A (ACN)
Broadcom (AVGO)
Johnson & Johnson (JNJ)
Home Depot (HD)
Thermo Fisher Scientific (TMO)

View all positions for Minot Wealth Management